C82.18
Follicular lymphoma grade II, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of non-Hodgkin lymphoma, a cancer that begins in the lymphatic system. Specifically, Follicular lymphoma grade II refers to a moderate level of cancer cell growth within the affected lymph nodes. When it involves lymph nodes across multiple sites, it indicates that the disease has spread beyond its initial location. This form of lymphoma can develop slowly, often presenting with enlarged lymph nodes that may not cause immediate symptoms. Recognizing and understanding this condition is vital for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal growth of lymphocytes Certain inherited genetic factors may increase susceptibility Environmental exposures, such as chemicals or toxins (though specific causes are not well established) Possible prior infections or immune system influences Age-related changes, as it predominantly affects older adults
Key Symptoms: Painless swelling of lymph nodes in areas such as the neck, armpits, or groin Persistent fatigue or tiredness Unexplained weight loss Night sweats Fever without an obvious infection Itching or skin discomfort (less common) Recurrent infections due to immune system impairment
Diagnostic & Treatment
Diagnosis Path: Doctors utilize a combination of methods to diagnose follicular lymphoma, including physical examinations, imaging tests like CT scans or PET scans to identify affected lymph nodes, and laboratory tests. A definitive diagnosis often requires a biopsy of a lymph node, where abnormal cells are examined under a microscope. Additional tests may include blood work to assess overall health and disease spread, as well as molecular studies to determine the genetic characteristics of the lymphoma.
Treatment Protocols: Treatment options for follicular lymphoma grade II depend on several factors, including disease stage, symptoms, and overall health. Approaches include: - Watchful waiting: Monitoring the condition without immediate treatment if the lymphoma is not causing symptoms. - Chemotherapy: Using drugs to kill cancer cells. - Immunotherapy: Employing medications like monoclonal antibodies to enhance the immune system’s ability to target cancer cells. - Targeted therapy: Using drugs that specifically target certain molecules involved in cancer growth. - Radiation therapy: Applying targeted radiation to affected lymph nodes. - Stem cell transplant: For certain cases, replacing diseased immune cells with healthy ones. The choice of treatment is individualized, often involving multidisciplinary teams to optimize outcomes.
Clinical Advice & FAQs
Billing Guidance
Is C82.18 a billable ICD-10 code?
Yes, C82.18 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.18?
Clinical documentation must specify the nature of Follicular lymphoma grade II, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
